WuXi PharmaTech Receives $3.2 Billion Privatization Offer

WuXi PharmaTech, China's largest CRO/CMO, announced a surprise privatization offer of $46 per ADS from Dr. Ge Li, the company's founder, chairman and CEO, and Ally Bridge Group Capital Partners. Before the offer, WuXi closed at $39.50. If the offer is completed, WuXi would be the largest privatization transaction in China's life science sector. Shortly after the New York opening, the company's stock is trading at $44.41, giving the company a market capitalization of over $3.1 billion and a trailing price-earnings ratio of 26. More details.... Stock Symbol: (NYSE:WX) Share this with colleagues: // //